Study on miscarriage management finds combination treatment is more efficient and cost effective

Aug. 28, 2023—Vanderbilt research finds that only 1% of 22,116 commercially insured women ages 15-49 with medically managed miscarriages received the recommended combination of mifepristone.

Read more